Découvrez le nouveau Chem-Impex : là où l'innovation commence par une liaison.

Catalog Number:
38182
CAS Number:
19171-19-8
Pomalidomide
Purity:
≥ 98 % (HPLC)
Synonym(s):
3-Amino- N -(2,6-dioxo-3-pipéridyl)phtalimide, 1,3-dioxo-2-(2,6-dioxopipéridin-3-yl)-4-aminoisoindoline,3-amino- N -(2,6-dioxo-3-pipéridyl)phtalamide
Documents
$18.53 /25 mg
Taille
Request Bulk Quote
Informations sur le produit

Pomalidomide is a potent immunomodulatory drug primarily used in the treatment of multiple myeloma, particularly in patients who have received prior therapies. This compound functions by enhancing the immune response against cancer cells and inhibiting the growth of tumor cells. Its unique structure allows it to modulate various cytokines and promote apoptosis in malignant cells, making it a valuable option in oncology. Pomalidomide is recognized for its effectiveness in combination therapies, often used alongside dexamethasone to improve patient outcomes.

In addition to its applications in cancer treatment, Pomalidomide is being explored for potential uses in other conditions, such as autoimmune diseases and certain viral infections, due to its ability to modulate immune responses. Researchers appreciate its favorable pharmacokinetic profile, which allows for flexible dosing regimens. With ongoing studies, Pomalidomide continues to demonstrate promise in expanding treatment options for challenging diseases, making it a significant compound in modern therapeutic strategies.

Numéro CAS 
19171-19-8
Formule moléculaire
C13H11N3O4
Poids moléculaire 
273.25
Point de fusion 
312 - 314 °C (déc.)
Informations générales
Numéro CAS 
19171-19-8
Formule moléculaire
C13H11N3O4
Poids moléculaire 
273.25
Point de fusion 
312 - 314 °C (déc.)
Propriétés
Informations complémentaires sur la propriété à venir prochainement !
-
Sécurité et réglementation
Matières dangereuses
-
Antibiotique
-
Réglementé par la DEA
Non
Avertissements 
-
Applications

Pomalidomide is widely utilized in research focused on:

  • Oncology Treatments: It is primarily used in the treatment of multiple myeloma, providing an effective option for patients who have not responded to other therapies.
  • Immunomodulation: Pomalidomide enhances immune responses, making it valuable in developing therapies that boost the body's ability to fight cancer.
  • Clinical Trials: Researchers are actively investigating its potential in combination therapies, exploring how it can be paired with other drugs to improve patient outcomes.
  • Hematology: Beyond cancer, it is being studied for its effects on various blood disorders, showcasing its versatility in treating different conditions.
  • Research on Mechanisms of Action: Scientists are examining how pomalidomide works at the molecular level, which could lead to the discovery of new therapeutic targets and strategies.

Citations